Europe Inhalation Anesthesia Market Size, Share & Industry Trends Analysis Report By Drug (Sevoflurane, Desflurane, Isoflurane, and Others), By Application (Maintenance and Induction), By Country and Growth Forecast, 2022 - 2028
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Europe Inhalation Anesthesia Market
Market Report Description
The Europe Inhalation Anesthesia Market would witness market growth of 8.5% CAGR during the forecast period (2022-2028).
During surgical procedures, anesthetic drugs are used to manage pain, respiration, blood pressure, blood flow, and heart rate and rhythm. Inhalational anesthesia is mostly used for sedation and induction of general anesthesia. Sevoflurane, desflurane, and nitrous oxide are the most often used inhalational anesthetics. Respiratory depression, a decrease in arterial blood pressure and cerebral metabolic demand, and an increase in cerebral blood flow are all common side effects of inhalational anesthetics. Nausea is the most prevalent side effect of inhalation anesthesia.
Halothane, isoflurane, nitrous oxide, sevoflurane, and desflurane are the most often utilized anesthetic gases. Inhalation through a face mask, laryngeal mask airway, or tracheal tube is the most common method of delivery. In the perioperative and intraoperative environment, they can be used in addition to intravenous (IV) anesthetic drugs such as midazolam and propofol for preoperative sedation.
According to estimates, the UK's healthcare spending in 2020 will be over £269 billion, including both government and non-government spending. Long-term care services relating to health are included. Between 2019 and 2020, total healthcare spending increased by 20% in nominal terms. This was by far the fastest year-over-year rate of increase in healthcare spending since the time series began in 1997.
In 2020, healthcare spending will account for 12.8 percent of GDP, up from 10.2 percent in 2019. The coronavirus pandemic had a substantial influence on both the healthcare sector and the wider economy, and this large increase was partially owing to very strong growth in healthcare expenditure but also partly due to a decline in GDP. The increase in healthcare expenditure is estimated to lead to an increase in the demand for inhalation anesthesia in the region.
The Germany market dominated the Europe Inhalation Anesthesia Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $124 Million by 2028. The UK market is anticipated to grow at a CAGR of 7.6% during (2022 - 2028). Additionally, The France market would display a CAGR of 9.3% during (2022 - 2028).
Based on Drug, the market is segmented into Sevoflurane, Desflurane, Isoflurane, and Others. Based on Application, the market is segmented into Maintenance and Induction. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Inhalation Anesthesia Market will Hit $1.9 Billion by 2028, at a CAGR of 8.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novartis AG, Piramal Enterprises Limited, Hikma Pharmaceuticals PLC, Fresenius SE & Co. KGaA, Baxter International, Inc., AbbVie, Inc., Halocarbon Products Corporation, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., and Troikaa Pharmaceuticals Limited.
Scope of the Study
Market Segments Covered in the Report:
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Novartis AG
- Piramal Enterprises Limited
- Hikma Pharmaceuticals PLC
- Fresenius SE & Co. KGaA
- Baxter International, Inc.
- AbbVie, Inc.
- Halocarbon Products Corporation
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Lunan Pharmaceutical Group Co., Ltd.
- Troikaa Pharmaceuticals Limited
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free